Mobile Clinical Trial Matching Technology in Medical Oncology Clinic: A Pilot Feasibility Study

Author:

Borno Hala T.12ORCID,Zhang Li13,Zhang Sylvia2ORCID,Kaplan Celia4,Palmer Nynikka R.256ORCID,Bell Alexander7ORCID,Bakke Brian7ORCID,Lin Amy12,Aggarwal Rahul12ORCID,Small Eric J.12ORCID

Affiliation:

1. Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA

2. Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

3. Department of Biostatistics, University of California, San Francisco, San Francisco, CA

4. Division of General Internal Medicine, University of California, San Francisco, San Francisco, CA

5. Department of Urology, University of California, San Francisco, San Francisco, CA

6. Division of General Internal Medicine at Zuckerberg San Francisco General, San Francisco, CA

7. School of Medicine, University of California, San Francisco, San Francisco, CA

Abstract

PURPOSE The internet is a common source of health information for patients and can be leveraged to provide patient-facing clinical trial information. This pilot study integrated an online prostate cancer clinical trial matching technology, called Trial Library (TL), in an academic medical oncology clinic from February 2019 to April 2021. PATIENTS AND METHODS This is a single-arm interventional pilot study among patients with a known prostate cancer diagnosis. Participants were given access to TL before seeing a provider. The primary and secondary study end points were the overall satisfaction with TL and the proportion of participant-initiated clinical trial discussion with providers after exposure to TL, respectively. The null hypothesis or true satisfaction rate (acceptability) was tested against a one-sided alternative and was rejected if 29 or more satisfactions were observed. RESULTS Among 272 patients approached, 66 provided informed consent to participate in the study. The mean age was 70.8 years (standard deviation = 7.9). The majority of participants were White (82%) and had metastases present at the time of enrollment (65%). The baseline clinical trial discussion rate ascertained via electronic medical record review was 28%. After accessing TL, a significantly larger proportion of participants (48.5%) discussed clinical trials during the clinic visit ( P = .007), half of which were patient-initiated. The majority of participants indicated that TL increased their interest in clinical trials (68.2%); however, satisfaction/extreme satisfaction with the technology was 38%. CONCLUSION Access to TL resulted in a significant increase in patient-initiated discussions regarding clinical trials and an increase in interest in clinical trial participation although these data do not address if this resulted in increased accrual to clinical trials. The satisfaction rate did not meet the target to reject the null hypothesis, suggesting the need for iterative design of patient-facing health information.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3